HBK INVESTMENTS L P

Q3 2021 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Isaac Haas - AUTHORIZED SIGNATORY
Location
Dallas, TX
Holdings as of
September 30, 2021
Value $
$1.39B
Num holdings
2
Date filed
8/15/2022, 12:12 PM
Description
Request for Confidential Treatment (8/15/2022): Confidential Treatment Expired on 5/16/2022. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2021 - Aug 16, 2021
Next filing
Q4 2021 - Feb 14, 2022
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 08-15-2022 pursuant to a request for confidential treatment and for which confidential treatment expired on 05-16-2022.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
ISAAC HAAS AUTHORIZED SIGNATORY Dallas, Texas 8/15/2022

HBK Investments L.P. has delegated discretion to vote and dispose of the securities described below to HBK Services LLC ("Services"). Services may, from time to time, delegate discretion to vote and dispose of certain of such Securities to one or more subadvisors. Each of Services and such subadvisors is under common control with HBK Investments L.P. The filing of this report shall not be deemed an admission that such subadvisors are, for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, beneficial owners of such securities.